Guidance

ILAP Performance Metrics and Innovation Passport list

Updated 21 January 2026

ILAP Quarterly Update - January 2026

In round two, three eligible applications progressed to full assessment by the ILAP Application Review Panel. While all met the eligibility requirements, none demonstrated sufficiently strong evidence across all three selection criteria to support the award of an Innovation Passport in this round. The ILAP is committed to accelerating access to transformative new medicines. We are strengthening feedback and enhancing guidance to better support future applicants in demonstrating strong evidence across all selection criteria.

Innovation Passport metrics (as of January 2026)

Eligible applications received 19
IPs awarded 3
IPs withdrawn 0

Performance metrics

Number of IP outcomes delivered within expected timeframes 19 out of 19 (100%)
Number of TDPs delivered within 6 months of IP award Not yet applicable – no TDPs have reached the 6-month delivery point.

Innovation Passport list

Download the latest Innovation Passport list.